+135.5%
EXPE vs THC
+413.3%
-277.7%
-37.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -4.9% | -1.1% | -3.8% | -4.6% |
| 7D | -9.3% | +3.7% | -13.0% | -9.9% |
| 30D | +0.1% | +9.0% | -8.9% | -1.5% |
| 3M | -15.3% | +10.4% | -25.7% | -16.9% |
| 6M | +5.5% | +45.7% | -40.2% | -2.0% |
| YTD | -8.0% | +42.6% | -50.5% | -14.9% |
| 1Y | +18.9% | +38.8% | -19.9% | +10.3% |
| 3Y | +135.5% | +418.8% | -283.3% | +26.6% |
| All | +135.5% | +413.3% | -277.7% | +26.6% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling